As expected, great results and an excellent conference call. It was great to hear Dr. Allan Gibofsky, the Rheumatologist who was trained in Ithaca, at the prestigious Cornell Univ. He has 39 years experience in Rheumatology. I really appreciated his answers.
Just a reminder: ACR50 takes the market for RA.
And the study showed 55% for ACR50!!
http://medical-dictionary.thefreedictionary.com/ACR 50 Response
PS: MESO up over 16% in after hours trading on the NASDAQ.
Outstanding Results!
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $21.32M | 17.21M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5460 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 978 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |